HKSE - Delayed Quote HKD

Zhongzhi Pharmaceutical Holdings Limited (3737.HK)

Compare
1.000
+0.010
+(1.01%)
At close: 3:49:44 PM GMT+8

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Mr. Zhi Tian Lai Chairman 2.06M -- 1968
Mr. Ying Feng Lai Chief Executive & Executive Director 1.48M -- 1992
Mr. Ying Sheng Lai CFO & Executive Director 1.25M -- 1994
Mr. Xiao Jun Cao Deputy GM & Executive Director 1.46M -- 1968
Ms. Wing Yan Ho A.C.I.S., A.C.S. Company Secretary -- -- 1982

Zhongzhi Pharmaceutical Holdings Limited

No. 3 Kangtai Road South
Torch Development Zone
Zhongshan
China
86 760 8533 1222 https://www.zeus.cn
Sector: 
Healthcare
Full Time Employees: 
2,736

Description

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. In addition, the company manufactures and sells food and Chinese herbs. Further, it offers detection and testing services; and manages properties. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.

Corporate Governance

Zhongzhi Pharmaceutical Holdings Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 24, 2024 at 12:00 AM UTC

Ex-Dividend Date